FR2538392B1 - Derives de type carboxamido de 5h-1,3,4-thiadiazolo (3,2-a) pyrimidine, procede pour leur preparation et composition pharmaceutique les contenant et presentant un effet analgesique et anti-inflammatoire - Google Patents

Derives de type carboxamido de 5h-1,3,4-thiadiazolo (3,2-a) pyrimidine, procede pour leur preparation et composition pharmaceutique les contenant et presentant un effet analgesique et anti-inflammatoire

Info

Publication number
FR2538392B1
FR2538392B1 FR8320704A FR8320704A FR2538392B1 FR 2538392 B1 FR2538392 B1 FR 2538392B1 FR 8320704 A FR8320704 A FR 8320704A FR 8320704 A FR8320704 A FR 8320704A FR 2538392 B1 FR2538392 B1 FR 2538392B1
Authority
FR
France
Prior art keywords
thiadiazolo
carboxamido
analgesic
pyrimidine
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8320704A
Other languages
English (en)
French (fr)
Other versions
FR2538392A1 (fr
Inventor
Gianfederico Doria
Carlo Passarotti
Ada Buttinoni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmitalia Carlo Erba SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838329746A external-priority patent/GB8329746D0/en
Application filed by Farmitalia Carlo Erba SRL filed Critical Farmitalia Carlo Erba SRL
Publication of FR2538392A1 publication Critical patent/FR2538392A1/fr
Application granted granted Critical
Publication of FR2538392B1 publication Critical patent/FR2538392B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/121,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/1251,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR8320704A 1982-12-23 1983-12-23 Derives de type carboxamido de 5h-1,3,4-thiadiazolo (3,2-a) pyrimidine, procede pour leur preparation et composition pharmaceutique les contenant et presentant un effet analgesique et anti-inflammatoire Expired FR2538392B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8236642 1982-12-23
GB838329746A GB8329746D0 (en) 1983-11-08 1983-11-08 Carboxamido-derivatives

Publications (2)

Publication Number Publication Date
FR2538392A1 FR2538392A1 (fr) 1984-06-29
FR2538392B1 true FR2538392B1 (fr) 1987-01-16

Family

ID=26284768

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8320704A Expired FR2538392B1 (fr) 1982-12-23 1983-12-23 Derives de type carboxamido de 5h-1,3,4-thiadiazolo (3,2-a) pyrimidine, procede pour leur preparation et composition pharmaceutique les contenant et presentant un effet analgesique et anti-inflammatoire

Country Status (15)

Country Link
US (1) US4522944A (cg-RX-API-DMAC7.html)
AT (1) AT385036B (cg-RX-API-DMAC7.html)
AU (1) AU558600B2 (cg-RX-API-DMAC7.html)
CA (1) CA1211440A (cg-RX-API-DMAC7.html)
CH (1) CH657136A5 (cg-RX-API-DMAC7.html)
DE (1) DE3346223A1 (cg-RX-API-DMAC7.html)
DK (1) DK593983A (cg-RX-API-DMAC7.html)
FI (1) FI834698A7 (cg-RX-API-DMAC7.html)
FR (1) FR2538392B1 (cg-RX-API-DMAC7.html)
GR (1) GR79479B (cg-RX-API-DMAC7.html)
IL (1) IL70522A (cg-RX-API-DMAC7.html)
IT (1) IT1194521B (cg-RX-API-DMAC7.html)
NL (1) NL8304340A (cg-RX-API-DMAC7.html)
SE (1) SE454698B (cg-RX-API-DMAC7.html)
SU (1) SU1297731A3 (cg-RX-API-DMAC7.html)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3702758A1 (de) * 1987-01-30 1988-09-29 Hoechst Ag Substituierte 3-phenyl-7h-thiazolo (3,2-b) (1,2,4) triazin-7-one, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung, sowie einige bei der herstellung der genannten verbindungen gebildete zwischenprodukte
CA2679754C (en) 2007-03-12 2018-08-07 Intra-Cellular Therapies, Inc. Substituted heterocycle fused gamma-carbolines synthesis
US9428506B2 (en) 2012-04-14 2016-08-30 Intra-Cellular Therapies, Inc. Substituted pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines for the treatment of nervous system disorders
EP2968320B1 (en) 2013-03-15 2020-11-11 Intra-Cellular Therapies, Inc. Organic compounds
DK3076967T3 (da) 2013-12-03 2021-10-25 Intra Cellular Therapies Inc Fremgangsmåder til behandling af residuelle symptomer på skizofreni
MX2016013046A (es) 2014-04-04 2017-02-15 Intra Cellular Therapies Inc Compuestos organicos.
CN106535898A (zh) 2014-04-04 2017-03-22 细胞内治疗公司 有机化合物
PL3838274T3 (pl) 2016-01-26 2024-04-02 Intra-Cellular Therapies, Inc. Pochodna pirydo[3',4':4,5]pirolo[1,2,3-DE]chinoksaliny do zastosowania w leczeniu zaburzeń OUN
WO2017172784A1 (en) 2016-03-28 2017-10-05 Intra-Cellular Therapies, Inc. Novel salts and crystals
JP2019510039A (ja) 2016-03-28 2019-04-11 イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. 新規組成物および方法
US11014925B2 (en) 2016-03-28 2021-05-25 Intra-Cellular Therapies, Inc. Co-crystals of 1-(4-fluoro-phenyl)-4-((6bR,1OaS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H- pyrido[3′,4′:4,51_pyrrolo [1,2,3-delqcuinoxalin-8-yl)-butan-1-one with nicotinamide or isonicotinamide
US11331316B2 (en) 2016-10-12 2022-05-17 Intra-Cellular Therapies, Inc. Amorphous solid dispersions
EP3562484B1 (en) 2016-12-29 2021-08-25 Intra-Cellular Therapies, Inc. Pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline derivatives useful in the treatment of cns disorders
US10961245B2 (en) 2016-12-29 2021-03-30 Intra-Cellular Therapies, Inc. Substituted heterocycle fused gamma-carbolines for treatment of central nervous system disorders
RU2767410C2 (ru) 2017-03-24 2022-03-17 Интра-Селлулар Терапиз, Инк. Новые композиции и способы
KR102667268B1 (ko) 2017-07-26 2024-05-17 인트라-셀룰라 써래피스, 인코퍼레이티드. 유기 화합물
EP3658145A4 (en) 2017-07-26 2021-04-21 Intra-Cellular Therapies, Inc. ORGANIC COMPOUNDS
CN112040940A (zh) 2018-03-23 2020-12-04 细胞内治疗公司 有机化合物
CN112384218B (zh) 2018-06-06 2024-04-26 细胞内治疗公司 盐和晶体
ES3028377T3 (en) 2018-06-08 2025-06-19 Intra Cellular Therapies Inc Fused gamma-carbolines for acute treatment of anxiety or depression
KR20250034203A (ko) 2018-06-11 2025-03-10 인트라-셀룰라 써래피스, 인코퍼레이티드. 치환된 헤테로환 융합 감마-카르볼린 합성
JP2022500362A (ja) 2018-08-29 2022-01-04 イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. 新規組成物および方法
AU2019331490B2 (en) 2018-08-31 2025-04-24 Intra-Cellular Therapies, Inc. Novel methods
CA3108553A1 (en) 2018-08-31 2020-03-05 Intra-Cellular Therapies, Inc. Novel methods
EP4134101A1 (en) 2019-07-07 2023-02-15 Intra-Cellular Therapies, Inc. Deuterated lumateperone for the treatment of the bipolar ii disorder
JP7261942B2 (ja) 2019-12-11 2023-04-20 イントラ-セルラー・セラピーズ・インコーポレイテッド 有機化合物
US12414948B2 (en) 2022-05-18 2025-09-16 Intra-Cellular Therapies, Inc. Methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5129981B2 (cg-RX-API-DMAC7.html) * 1973-07-17 1976-08-28
GB1568962A (en) * 1975-10-31 1980-06-11 Beecham Group Ltd Reparation and compositions containing them (heterocyclic-carbonylamino)pencillins methods for their p
JPS55115889A (en) * 1979-02-28 1980-09-06 Teijin Ltd 6-carbamoylthiazolo 3,2-a pyrimidine derivative and its preparation
JPS57142989A (en) * 1981-02-27 1982-09-03 Dai Ichi Seiyaku Co Ltd Thiazolopyrimidine derivative

Also Published As

Publication number Publication date
FR2538392A1 (fr) 1984-06-29
IT1194521B (it) 1988-09-22
AT385036B (de) 1988-02-10
FI834698A0 (fi) 1983-12-20
SU1297731A3 (ru) 1987-03-15
IT8324207A0 (it) 1983-12-16
AU2252583A (en) 1984-06-28
GR79479B (cg-RX-API-DMAC7.html) 1984-10-30
AU558600B2 (en) 1987-02-05
DK593983D0 (da) 1983-12-22
US4522944A (en) 1985-06-11
FI834698A7 (fi) 1984-06-24
DK593983A (da) 1984-06-24
CH657136A5 (de) 1986-08-15
ATA438383A (de) 1987-07-15
IL70522A (en) 1986-02-28
CA1211440A (en) 1986-09-16
SE454698B (sv) 1988-05-24
DE3346223A1 (de) 1984-06-28
SE8307133L (sv) 1984-06-24
NL8304340A (nl) 1984-07-16
IL70522A0 (en) 1984-03-30
SE8307133D0 (sv) 1983-12-22

Similar Documents

Publication Publication Date Title
FR2538392B1 (fr) Derives de type carboxamido de 5h-1,3,4-thiadiazolo (3,2-a) pyrimidine, procede pour leur preparation et composition pharmaceutique les contenant et presentant un effet analgesique et anti-inflammatoire
FR2569402B1 (fr) Derives d'acide 3,5-pyridine-dicarboxylique, procede pour leur preparation et composition pharmaceutique les contenant
FR2567131B1 (fr) Nouveaux derives de ganglioside, procede pour leur obtention et composition pharmaceutique les contenant
PT83896A (fr) Procede pour la preparation de nouveaux conjuges de la vinblas-tine et de ses derives et de compositions pharmaceutiques les contenant
PT76573B (fr) Procede de preparation de derives d'imidazo <1,2-a> pyridine et de compositions pharmaceutiques les contenant
BE892552A (fr) Nouveaux amido-aminoacides, compositions pharmaceutiques les contenant et procede de preparation de ces amido-aminoacides
PT78275B (fr) Procede de preparation de nouveaux acides flavone-carboxyliques-4' et de compositions pharmaceutiques les contenant
FR2562071B1 (fr) Triazolo(4,3-b)pyridazines, procede pour leur preparation et compositions pharmaceutiques les contenant
PT74652A (fr) Procede de preparation de derives d'imidazo <1,2-a> pyrimidines et de compositions pharmaceutiques les contenant
FR2600061B1 (fr) Derives d'indole, composition pharmaceutique les contenant et procede pour leur preparation
BE870576A (fr) Nouveaux acides dialkylamino-7 halogeno-6 oxo-4 dihydro-1,4 quinoleine-3 carboxyliques, procede pour leur preparation et compositions les contenant
PT82364B (fr) Procede de preparation de derives du nitrofuranne et de compositions pharmaceutiques les contenant
FR2563519B1 (fr) Derives d'iminothiazolidine, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2526425B1 (fr) Derives de cycloalcanes, procede pour leur preparation et compositions les contenant
PT80920A (fr) Procede pour la preparation d'imidazo<1,2-a>quinolines et de compositions pharmaceutiques les contenant
FR2503713B1 (fr) 2,3-di-substitue-5,6-dihydro-imidazo-(2,1-b) thiazoles, procede pour leur preparation et agents anti-inflammatoires les contenant
FR2528422B1 (fr) Nouveaux derives du 1,2,3,4-tetrahydronaphtalene, procede pour leur preparation et composition pharmaceutique contenant ces derives
FR2326193A1 (fr) Nouveaux derives de 5,6-dihydro pyrimidin-4(3h)-one procede pour leur preparation et compositions pharmaceutiques les contenant
FR2513994B1 (fr) Tripeptides anorexigenes, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2560193B1 (fr) Derives d'aminodiaryl sulfoxyde, procede pour leur preparation et compositions pharmaceutiques et pesticides les contenant
FR2517672B1 (fr) Thioalcanoyl-carnitines, procede pour leur preparation et composition pharmaceutique les contenant
FR2598417B1 (fr) Esters d'azoniaspironortropanols, procede pour leur preparation et medicaments les contenant
FR2492384B1 (fr) Procede de preparation de nouveaux composes cytostatiques et compositions pharmaceutiques les contenant
PT82853A (fr) Procede de preparation de nouveaux benzamides et des compositions pharmaceutiques les contenant
FR2563520B1 (fr) Nouveaux derives d'apovincaminol, procede pour leur preparation et compositions pharmaceutiques les contenant

Legal Events

Date Code Title Description
ST Notification of lapse